INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2018 |
Mar. 31, 2017 |
|
| Operating expenses: | ||
| Research and development, net | $ 977 | $ 941 |
| General and administrative | 1,330 | 829 |
| Operating loss | (2,307) | (1,770) |
| Financial expenses (income), net | (9) | 15 |
| Net loss | $ (2,298) | $ (1,785) |
| Basic and diluted net loss per share from continuing operations | $ (0.12) | $ (0.1) |
| Weighted average number of shares outstanding used in computing basic and diluted net loss per share | 19,047,350 | 18,688,377 |